SIRT1 and fatty liver disease: Moreover, deletion of Sirt1 impaired liver regeneration, as evidenced by a decreased liver-to-body weight ratio, reduced indices of hepatocyte proliferation (Figure 1, A–D), and lead to hepatic steatosis as reflected in histology and hepatic triglyceride content (Figure 1, E and F).